Electrophoresis Reagents Market - Forecast(2025 - 2031)

Report Code: HCR 0473 Report Format: PDF + Excel

Electrophoresis Reagents Market Overview 

The Electrophoresis Reagents market size is estimated to reach $4569 Million by 2030, growing at a CAGR of 5.7% during the forecast period 2024-2030. Electrophoresis is a laboratory technique in which an electric current is used to separate protein, RNA or DNA molecules. Some of the major reagents used in the electrophoresis process include Agarose gel, TBE buffers, Bromophenol Blue and Starch gels. Electrophoresis is used by various healthcare facilities for applications like DNA & RNA analysis, and Protein Analysis. The rising applications of Next Generation Sequencing (NGS) and growth in public and private investment in the healthcare sector of developing regions are anticipated to drive the market during the forecast period. However, lack of adequate regulations and quality standards regarding the manufacture of reagents act as a challenge for the Electrophoresis Reagents industry.

Report Coverage

The report: “Electrophoresis Reagents Market Forecast (2024-2030)”, by Industry ARC, covers an in-depth analysis of the following segments of the Electrophoresis Reagents Market.
By Technique: Gel Electrophoresis, Capillary Electrophoresis, Electrophoresis Software and Others.
By Application: Protein Analysis, and DNA & RNA Analysis.
By End User: Pharmaceutical & Biotechnological Companies, Hospitals & Clinics, Academic Institutes& Research Laboratories, Forensic Laboratories and Others.
By Geography: North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, and Rest of South America) and Rest of World (Middle East and Africa). 

Key Takeaways

  • Geographically, the North American Electrophoresis Reagents market accounted for the largest share in 2020 owing to an increase in R&D expenditure and improving research infrastructure in the region.
  • An increase in the prevalence of chronic diseases is driving the demand for Electrophoresis Reagents. However, the lack of adequate research institutes and laboratories in developing regions is challenging the demand generation.
  • Detailed analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Electrophoresis Reagents Market Report. 
     
Electrophoresis Reagents Market Share, By Geography, 2020(%)
Electrophoresis Reagents Market
For more details on this report - Request for Sample

Electrophoresis Reagents Market Segment Analysis-By Technique

Based on Technique, the Electrophoresis Reagents Market is segmented into Gel Electrophoresis, Capillary Electrophoresis, Electrophoresis Software and Other techniques. The Gel Electrophoresis segment is anticipated to have the largest share of the market and is poised to dominate the market during the forecast period 2021-2026. Moreover, the segment is also projected to grow the fastest at a CAGR of 6.1% during the forecast period. This rapid growth is attributed to the fact that gel technique enables easy processing of DNA molecules and also allows them to be recovered without risk of denaturing the DNA samples. Furthermore, the growing applications of gel electrophoresis in forensic sciences is further contributing to the development of the market. For instance, gel electrophoresis can be used for the process of DNA fingerprinting.

Electrophoresis Reagents Market Segment Analysis-By End User

The Electrophoresis Reagents Market based on End User can be further segmented into Pharmaceutical & Biotechnological Companies, Hospitals & Clinics, Academic Institutes& Research Laboratories, Forensic Laboratories and Others. The Pharmaceutical & Biotechnological Companies segment accounted for the largest share of the market in 2020 owing to the rise in private and public R&D expenditure. This can be attributed to the Covid-19 pandemic and the emergence of new variants of the virus. Electrophoresis’ ability to separate DNA and RNA play a major role in viral research and development of effective therapies for the virus. The Hospitals & Clinics segment is also anticipated to witness significant growth at a CAGR of 6.3% during the forecast period owing to the increase in the prevalence of chronic diseases such as cancer, diabetes, and cardiovascular disorders.

Electrophoresis Reagents Market Segment Analysis-By Geography

The Electrophoresis Reagents Market based on Geography can be segmented into North America, Europe, Asia-Pacific, South America, and Rest of World. The North American segment is projected to dominate the Electrophoresis Reagents market during the forecast period 2021-2026 with a market share of 32% owing to the presence of highly developed healthcare infrastructure, surging incidences of chronic and communicable diseases, and growing geriatric population in the region. Moreover, the presence of key industry players such as Thermo Fisher Scientific, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Merck Millipore, GE Healthcare and Agilent Technologies in the region ensures lower costs, higher innovation, and greater frequency of new product launches in the region. The Asia-Pacific region is anticipated to grow the fastest during the forecast period owing to the growth in academic & research institutes, pharmaceutical & biotechnology companies and healthcare expenditure in emerging economies such as China, Indonesia and India.

Electrophoresis Reagents Market Drivers

Increase in Global Research Expenditure is Projected to Drive Market Growth.

The increase in public and private expenditure on R&D by global biopharmaceutical companies and research institutes is driving the market for electrophoresis reagents. For instance, the R&D expenditure of pharmaceutical research and manufacturers of America (PhRMA) member companies increased from $48.6 billion in 2011 to $91.1 billion in 2020. According to the US Congressional Budget Office (CBO), the number of new drugs approved for sale rose by 60% between 2010 and 2019. Pharmaceutical company Pfizer increased their R&D expenditure to $9.4 billion in 2020 from $8.65 billion in 2019. This rise in R&D will increase demand as electrophoresis is necessary for various fields such as drug discovery, cancer research and virus research.

Rise in Chronic Illnesses is Anticipated to Boost Product Demand.

The surge in chronic illnesses such as cancer, diabetes and cardiovascular diseases is driving the market for Electrophoresis Reagents. Around 463 million adults between the ages of 20 and 79 were living with diabetes in 2019. This is projected to reach 700 million by 2045. The disease resulted in 4.2 million deaths and $760 billion in healthcare expenditure in 2019. Moreover, around 19.3 million new cancer cases and 10 million cancer deaths took place globally in 2020. Furthermore, according to WHO, Cardiovascular diseases are the leading cause of death globally, taking an estimated 17.9 million lives each year. Electrophoresis Reagents are essential for studying such diseases and also for diagnosing cancers such as multiple myeloma.

Electrophoresis Reagents Market Challenges 

The Various Limitations of Electrophoresis is Anticipated to Hamper Market Growth.

The various limitations and disadvantages of current electrophoresis and reagent technology act as a major challenge for generating demand. For instance, the process of gel electrophoresis may cause the gel reagent to melt when electric current is passed through them. This may result in increased risk of causing the genetic material to change shape. Moreover, Gel electrophoresis technique also has a low throughput. This means that the data is not generated rapidly as only a small handful of RNA molecules can be looked at a time. Researchers are therefore using faster alternatives such as Polymerase Chain Reaction (PCR) technique, which can can simultaneously assess thousands of samples.

Lack of Adequate Hospitals and Research Facilities is Projected to Limit Growth Opportunities

The lack of adequate hospitals, doctors, research facilities, and pharmaceutical organizations in low and middle-income countries is challenging the demand for Electrophoresis Reagents as they are some of the primary end users of the product. For instance, the number of physicians per million population in developing regions such as Cameroon, Zimbabwe, Ghana and Guinea are 80, 83, 96, and 100 respectively. This is much lower than the developed countries like the US or Spain, whose physicians per capita values are 2600 and 3900 per million respectively. The lack of adequate doctors, research facilities and hospitals can be attributed to the low healthcare expenditure of these countries. For instance, according to the WHO database, the annual per capita healthcare expenditure in South Africa and Bangladesh was only $525.9 and $41.9 respectively. This is extremely low compared to developed countries such as the US who spent around $10623.8 per capita.

Electrophoresis Reagents Market Industry Outlook:

Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Electrophoresis Reagents Market. Top 10 companies of the industry include:

  1. Thermo Fisher Scientific
  2. Sigma-Aldrich Corporation
  3. Bio-Rad Laboratories, Inc
  4. Lonza Group
  5. QIAGEN N.V.
  6. Merck Millipore
  7. GE Healthcare
  8. Agilent Technologies, Inc.
  9. Sebia Group
  10. Takara Bio Inc
  11. Merck Group

Partnerships/Product Launches:

  •  In September 2020, Hitachi High-Tech Corporation announced the launch of the Hitachi DS3000 compact capillary electrophoresis (CE) sequencer will be released for sale in Japan, China, South Korea and Taiwan. The new sequencer provides superior performance and processing in a compact form, owing to its capillary and laser-irradiation technologies. 
  • In November 2019, Thermo Fisher Scientific announced the introduction of their latest forensic laboratory-qualified capillary electrophoresis platform. It is designed for small to medium-sized forensic DNA analysis and has been validated according to Scientific Working Group on DNA Analysis Methods (SWGDAM) guidelines across a broad range of Applied Biosystems STR Amplification Kits.

Relevant Reports:

 

 

Report Code: HCR 0415

 

 

 

Report Code: HCR 0278
 
For more Lifesciences and Healthcare related reports, please click here

 

 

 

 

1. Electrophoresis Reagents Market - Overview
    1.1 Definitions and Scope
2. Electrophoresis Reagents Market - Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product Type
    2.3 Key trends by End User
    2.4 Key trends by Geography
3. Electrophoresis Reagents Market – Comparative Analysis
    3.1 Company Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis
    3.5 Pricing Analysis – Average Selling Price
4. Electrophoresis Reagents Market - Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Electrophoresis Reagents Market – Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Electrophoresis Reagents Market - Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Electrophoresis Reagents Market – Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Electrophoresis Reagents Market – By Product Type (Market Size –$Million/$Billion)
    8.1 Gels
        8.1.1 Agarose Gels
        8.1.2 Polyacrylamide Gels
        8.1.3 Starch Gels
    8.2 Dyes
        8.2.1 Ethidium Bromide (ETBR) Dyes
        8.2.2 Bromophenol Blue
        8.2.3 SYBR Dyes
        8.2.4 Other Dyes
    8.3 Buffers
        8.3.1 Tris/Acetate/EDTA
        8.3.2 Tris/ Borate/EDTA
        8.3.3 Other Buffers
    8.4 Others
9. Electrophoresis Reagents Market – By Techniques (Market Size –$Million/$Billion)
    9.1 Gel Electrophoresis
        9.1.1 Agarose Gel Electrophoresis
        9.1.2 Polyacrylamide Gel Electrophoresis
    9.2 Capillary Electrophoresis
        9.2.1 Capillary zone Electrophoresis
        9.2.2 Capillary Isoelectric Focusing
        9.2.3 Capillary Isotachophoresis
        9.2.4 Capillary Gel Electrophoresis
        9.2.5 Micellar Electrokinetic Capillary Chromatography
        9.2.6 Capillary Electro-chromatography
    9.3 Electrophoresis Software
    9.4 Others
10. Electrophoresis Reagents Market – By Application (Market Size –$Million/$Billion)
    10.1 Protein Analysis
    10.2 DNA & RNA Analysis
11. Electrophoresis Reagents Market - By End User (Market Size –$Million/$Billion)
    11.1 Pharmaceutical & Biotechnological Companies
    11.2 Hospitals & Clinics
    11.3 Academic Institutes& Research Laboratories
    11.4 Forensic Laboratories
    11.5 Others.
12. Electrophoresis Reagents Market - By Geography (Market Size –$Million/$Billion)
    12.1 North America
        12.1.1 U.S.
        12.1.2 Mexico
        12.1.3 Canada
    12.2 Europe
        12.2.1 U.K.
        12.2.2 France
        12.2.3 Germany
        12.2.4 Italy
        12.2.5 Spain
        12.2.6 Russia
        12.2.7 Rest of Europe
    12.3 Asia Pacific
        12.3.1 China
        12.3.2 India
        12.3.3 Japan
        12.3.4 South Korea
        12.3.5 Australia & New Zealand
        12.3.6 Rest of Asia Pacific
    12.4 South America
        12.4.1 Brazil
        12.4.2 Argentina
        12.4.3 Rest of South America
    12.5 Rest of the World
        12.5.1 Middle East
        12.5.2 Africa
13. Electrophoresis Reagents Market - Entropy
14. Electrophoresis Reagents Market – Industry/Segment Competition Landscape Premium
    14.1 Market Share Analysis
        14.1.1 Global Market Share – Key Companies
        14.1.2 Market Share by Region – Key companies
        14.1.3 Market Share by Countries – Key Companies
        14.1.4 Competition Matrix
        14.1.5 Best Practices for Companies
15. Electrophoresis Reagents Market – Key Company List by Country Premium Premium
16. Electrophoresis Reagents Market Company Analysis
    16.1 Merck Group
    16.2 Agilent Technologies, Inc.
    16.3 GE Healthcare
    16.4 Bio-Rad Laboratories, Inc
    16.5 Thermo Fisher Scientific
    16.6 Company 6
    16.7 Company 7
    16.8 Company 8
    16.9 Company 9
    16.10 Company 10
"*Financials for private companies would be provided on a best-efforts basis”.